Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Times Interest Earned (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Times Interest Earned for 9 consecutive years, with -$10.26 as the latest value for Q3 2023.

  • Quarterly Times Interest Earned fell 414.76% to -$10.26 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$38.48 through Jun 2024, down 158.84% year-over-year, with the annual reading at -$30.5 for FY2023, 735.96% down from the prior year.
  • Times Interest Earned for Q3 2023 was -$10.26 at Cartesian Therapeutics, up from -$24.78 in the prior quarter.
  • The five-year high for Times Interest Earned was $19.38 in Q2 2022, with the low at -$79.84 in Q2 2020.
  • Average Times Interest Earned over 5 years is -$19.9, with a median of -$11.08 recorded in 2020.
  • The sharpest move saw Times Interest Earned surged 2949.22% in 2022, then tumbled 414.76% in 2023.
  • Over 5 years, Times Interest Earned stood at -$37.52 in 2019, then soared by 70.48% to -$11.08 in 2020, then surged by 151.78% to $5.74 in 2021, then crashed by 283.55% to -$10.53 in 2022, then grew by 2.51% to -$10.26 in 2023.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$10.26, -$24.78, and -$22.75 for Q3 2023, Q2 2023, and Q1 2023 respectively.